APYX vs MSCI · rev $48.1M vs P/E 37, rev $2.86B
Apyx Medical Inc (APYX) versus MSCI Inc (MSCI) — a side-by-side from cached financials, not a winner call.
Apyx Medical Inc (APYX) is a medical devices company listed on US.
MSCI Inc (MSCI) is a financial data & stock exchanges company listed on US.
Latest reported APYX revenue for 2024-12-31 was $48.1M. Net income was -$23.6M. Revenue was down 8.1% from 2023-12-31 to 2024-12-31. APYX currently screens at market cap $179.6M.
Latest reported MSCI revenue for 2024-12-31 was $2.86B. Net income was $1.11B. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
APYX currently screens at market cap $179.6M. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
Not investment advice. Open the APYX and MSCI stock pages for the full models.
Not investment advice.